Stryker Corporation

Stryker Corporation is a medical technology company based in the United States, operating globally. Its business is organized into two segments: MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication and AI-assisted virtual care platforms, and minimally invasive products for treating acute ischemic and hemorrhagic stroke and venous thromboembolism. It also includes products for traditional brain and open skull-based surgeries, as well as orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for total joint replacements (hip, knee, shoulder, ankle), trauma and extremities surgeries, and the Mako Shoulder robotic system.

Stryker Corporation is listed on the New York Stock Exchange (NYSE) under the ticker symbol SYK. Its financials are reported in US Dollars (USD), as the company is headquartered in the United States. The exchange and currency are consistent with its primary listing in the US market.

Stryker Corporation operates in the Healthcare sector and specifically within the Medical Devices industry. As a medical technology company, it develops and sells a wide range of products used in surgical procedures, patient care, and orthopedic implants. Its industry focuses on devices and equipment that support medical treatments, from hospital beds and surgical navigation systems to joint replacement implants and neurotechnology for stroke treatment.

Stryker Corporation is headquartered in Portage, Michigan, United States. Founded in 1941, the company sells its products to doctors, hospitals, and healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. While its primary market is the United States, its global reach extends across multiple regions, making it a significant player in the international medical device market.

Stryker generates revenue by selling medical devices and equipment across two main segments. The MedSurg and Neurotechnology segment contributes through surgical equipment, patient handling systems, emergency medical equipment, and neurotechnology products for stroke and venous thromboembolism treatment. The Orthopaedics segment earns revenue from implants used in joint replacement surgeries (hip, knee, shoulder, ankle) and trauma procedures, as well as robotic systems like Mako Shoulder. The company sells directly via its own subsidiaries and branches, and also through third-party distributors, reaching customers in about 61 countries. Its diverse portfolio of products for hospitals and healthcare facilities drives its income.